CG
SRNE

Cutler Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cutler Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,100
Closed – – 5081
2022
Q4 		$0 Sell
1,100
-2,100
-66% -$2.79K ﹤0.01% 5569
2022
Q3 		$5K Buy
3,200
+1,300
+68% +$2.95K ﹤0.01% 3737
2022
Q2 		$3K Buy
1,900
+1,000
+111% +$1.73K ﹤0.01% 4177
2022
Q1 		$2K Sell
900
-2,200
-71% -$6.86K ﹤0.01% 4846
2021
Q4 		$14K Sell
3,100
-400
-11% -$2.48K ﹤0.01% 3455
2021
Q3 		$26K Sell
3,500
-1,700
-33% -$14.4K ﹤0.01% 3119
2021
Q2 		$50K Buy
5,200
+500
+11% +$3.98K ﹤0.01% 2493
2021
Q1 		$38K Hold
4,700
– – ﹤0.01% 2652
2020
Q4 		$32K Buy
4,700
+290
+7% +$2.33K ﹤0.01% 2327
2020
Q3 		$49K Sell
4,410
-1,690
-28% -$15.5K ﹤0.01% 1818
2020
Q2 		$38K Buy
6,100
+5,800
+1,933% +$22.2K ﹤0.01% 1937
2020
Q1 		$0 Hold
300
– – ﹤0.01% 4874
2019
Q4 		$1K Buy
+300
New +$715 ﹤0.01% 3836
2018
Q2 		– Sell
-100
Closed – – 5116
2018
Q1 		$0 Buy
+100
New +$711 ﹤0.01% 5488
2017
Q4 		– Sell
-100
Closed – – 6232
2017
Q3 		$0 Hold
100
– – ﹤0.01% 6985
2017
Q2 		$0 Sell
100
-453
-82% -$884 ﹤0.01% 7323
2017
Q1 		$2K Sell
553
-800
-59% -$4.01K ﹤0.01% 5616
2016
Q4 		$6K Buy
+1,353
New +$8.13K ﹤0.01% 4815
2016
Q3 		– Sell
-953
Closed -$6.42K – 7585
2016
Q2 		$5K Sell
953
-1,400
-59% -$8.95K ﹤0.01% 5006
2016
Q1 		$12K Buy
2,353
+2,314
+5,933% +$13.5K ﹤0.01% 3891
2015
Q4 		$0 Buy
+39
New +$329 ﹤0.01% 6396

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Cutler Group's SRNE Position: Q1 2023 in Review

Cutler Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 1,100 shares.

Cutler Group first reported a position in SRNE in Q4 2015 and held it in 21 quarters. The position peaked at $50K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Cutler Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 1,100 Sorrento Therapeutics, Inc. shares in Q1 2023.
  • Cutler Group first reported a position in Sorrento Therapeutics, Inc. in Q4 2015 and held it in 21 quarters.
  • Cutler Group's Sorrento Therapeutics, Inc. position peaked at $50K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.